Assessment of the quality of life after discharge from the ICU: a comparison of COVID-19 and non-COVID-19 patients

Titolo Rivista SALUTE E SOCIETÀ
Autori/Curatori Vincenzo Auriemma, Ivana Ferrara, Ester Miranda, Salvatore Patti, Daniela Baldassarre, Giuliana Scarpati, Gennaro Iorio, Ornella Piazza
Anno di pubblicazione 2025 Fascicolo 2025/1
Lingua Inglese Numero pagine 12 P. 145-156 Dimensione file 291 KB
DOI 10.3280/SES2025-001010
Il DOI è il codice a barre della proprietà intellettuale: per saperne di più clicca qui

Qui sotto puoi vedere in anteprima la prima pagina di questo articolo.

Se questo articolo ti interessa, lo puoi acquistare (e scaricare in formato pdf) seguendo le facili indicazioni per acquistare il download credit. Acquista Download Credits per scaricare questo Articolo in formato PDF

Anteprima articolo

FrancoAngeli è membro della Publishers International Linking Association, Inc (PILA)associazione indipendente e non profit per facilitare (attraverso i servizi tecnologici implementati da CrossRef.org) l’accesso degli studiosi ai contenuti digitali nelle pubblicazioni professionali e scientifiche

Background: The World Health Organization (WHO) has declared that the COVID-19 pandemic has had a serious impact on the mental health and well-being of people worldwide. Method: The authors conducted an observational pilot study, considering two patient cohorts: the first sample of 20 non-COVID-19 patients admitted to the ICU from September 2019 to September 2020 and the second sample of 26 COVID-19 patients admitted to the ICU from October 2020 and April 2021. Participants were contacted for a telephone interview within six months after discharge. Results: The quality of life, calculated through the SF-12, of patients admitted for COVID- 19 in 2020-21 is worse than the sample discharged from the ICU in the previous period, 2019-2020. Conclusions: The quality of life indices that emerged in both the pandemic and prepandemic eras were lower than average, but when comparing the two cohorts, the indices collected in the pandemic era were lower.

Keywords:quality of life; COVID-19; intensive care; questionnaire SF-12; comparative research; post-COVID-19.

  1. Balasubramanian A., Paleri V., Bennett R., Paleri V. (2020). Impact of COVID-19 on the mental health of surgeons and coping strategies. Head Neck, 42(7): 1638-1644.
  2. Bellan M., Baricich A., Patrucco F. et al. (2021). Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep, 11(1): 22666.
  3. Bloomer M.J., Bouchoucha S. (2020). Editorial: COVID-19 and what it means for end-of-life care in ICU: Balancing the priorities. Collegian, 27(3): 248–249.
  4. Counts N.Z., Staglin B., Rosenberg L. (2020). Mental Health for US. The Lancet Psychiatry, 7(4): 299-300. DOI: 10.1016/S2215-0366(19)30377-
  5. Hayes L.D., Ingram J., Sculthorpe N.F. (2021). More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Frontiers in Medicine, 8:750378.
  6. Huang C., Huang L., Wang Y. et al. (2023). Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England), 401(10393) DOI: 10.1016/S01406736(23)01175-
  7. ISTAT DATA (2020). Stato di Salute. -- https://www.istat.it/it/files/2011/02/metadati.pdf (10/05/2021).
  8. Levkovich I., Shinan-Altman S. (2021). Impact of the COVID-19 pandemic on stress and emotional reactions in Israel: a mixed-methods study. International Health, 13(4), pp. 358–366.
  9. Li J., Xia W., Zhan C. et al. (2022). A telerehabilitation programme in postdischarge COVID-19 patients (TERECO): A randomised controlled trial. Thorax, 77(7): 697–706.
  10. Marconi M. (2020). Differenze di genere in COVID-19: l’importanza dei dati disaggregati per sesso. EpiCentro, ISS. -- Testo disponibile al sito: https://www.epicentro.iss.it/coronavirus/sars-cov-2-differenze-genere- importanza-dati-disaggregati (23/06/2022)
  11. Martino M., Aboud N., Cola M.F. et al. (2021). Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: The CORTICOVID study. J Endocrinol Invest., 44(5): 1075-1084.
  12. Ortolan A., Lorenzin M., Felicetti M., Doria A., Ramonda R. (2020). Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. International Journal of Infectious Diseases, 99: 496-504.
  13. RECOVERY Collaborative Group (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 397(10285): 1637-1645. DOI: 10.1016/S01406736(21)00676-
  14. Rivi V., Melegari G., Blom J.M.C. (2021). How to humanise the COVID-19 intensive care units. BMJ Evidence-Based Medicine, 26(4): 141-142.
  15. Salvarani C., Dolci G., Massari M. et al. (2021). Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial. JAMA Internal Medicine, 181(1): 24-31.

Vincenzo Auriemma, Ivana Ferrara, Ester Miranda, Salvatore Patti, Daniela Baldassarre, Giuliana Scarpati, Gennaro Iorio, Ornella Piazza, Assessment of the quality of life after discharge from the ICU: a comparison of COVID-19 and non-COVID-19 patients in "SALUTE E SOCIETÀ" 1/2025, pp 145-156, DOI: 10.3280/SES2025-001010